今日关注 申购提示：今日3只新股申购。 商务部：已批准部分稀土出口通用许可申请。 10．当地时间18日，英国央行英格兰银行宣布，将基准利率由此前的4%下调至3.75%。这是2024年8月 以来的第6次降息，也是英国自2023年2月以来的最低基准利率。 4．商务部新闻发言人何亚东在12月18日举行的例行新闻发布会上说，中方注意到，欧委会近期密集对 中国企业发起《外国补贴条例》（FSR）调查，先后对中车集团、同方威视发起深入调查，甚至对中国 数字平台进行现场突袭检查，做法恶劣，指向性和歧视性明显。中方对此强烈反对。希望欧方立即停止 对包括中国在内的外国投资企业的无理打压，审慎使用FSR调查工具，为在欧投资经营企业创造公平、 公正、可预期的营商环境。中方密切关注欧方有关动向，将采取必要措施，坚决维护中国企业合法权 益。 5．香港交易所于12月18日刊发《优化香港证券市场每手买卖单位框架》的咨询文件，主要包含以下三 个部分：1.将每手价值的指引下限从2000港元降至1000港元。2.增设50000港元的每手价值指引上限。3. 将每手股数的种类减至八种标准化的选项：1股、50股、100股、500股、1000股、2000 ...

Group 1 - New stock offerings include Qiangyi Co. with an issuance price of 85.09 CNY per share and a subscription limit of 0.75 million shares, Yufan Technology at 22.29 CNY per share with a limit of 0.85 million shares, and Shuangxin Environmental Protection at 6.85 CNY per share with a limit of 60 million shares [2] - The Ministry of Commerce announced that some Chinese exporters have met the basic requirements for applying for general licenses regarding rare earth export controls, with some applications already approved [3] - The Hong Kong Stock Exchange is proposing a new trading unit framework to enhance market efficiency and reduce investment thresholds, which includes lowering the minimum value for trading units from 2000 HKD to 1000 HKD [4] Group 2 - The State Council issued guidelines to combat illegal activities related to tobacco, aiming to address issues such as counterfeiting and smuggling [4] - The State-owned Assets Supervision and Administration Commission released measures for accountability in investment violations, categorizing asset losses and defining responsibilities based on severity [5] - The Ministry of Industry and Information Technology announced that the photovoltaic industry will enter a critical governance phase by 2026, focusing on capacity regulation and management of manufacturing projects [5] Group 3 - The Bank of England announced a reduction in the benchmark interest rate from 4% to 3.75%, marking the lowest rate since February 2023 [6] - Haitian Flavor Industry plans to distribute a special dividend of 3 CNY per share [8] - Sichuan Road and Bridge has been acquired by Zhongyou Insurance, reaching a 5% shareholding [8]

Core Viewpoint - Luyuan Pharmaceutical (002788) has added the "AI Medical" concept due to its development in three core AI medical application areas: intelligent diagnostic equipment, medical service intelligence upgrades, and drug traceability intelligence [1] Group 1: Company Overview - Luyuan Pharmaceutical's main business includes the distribution of pharmaceuticals, traditional Chinese medicine pieces, medical devices, and retail pharmacy chains [1] - The company is also associated with other concept sectors such as elderly care, artificial intelligence, smart healthcare, the Straits West Coast, and cold chain logistics [1] Group 2: Financial Performance - For the first three quarters of 2025, Luyuan Pharmaceutical reported a main revenue of 15.855 billion yuan, an increase of 2.87% year-on-year [1] - The net profit attributable to shareholders was 220 million yuan, a decrease of 14.64% year-on-year, while the net profit excluding non-recurring items was also 220 million yuan, down 15.14% year-on-year [1] - In the third quarter of 2025, the company achieved a single-quarter main revenue of 5.455 billion yuan, up 6.81% year-on-year, with a net profit attributable to shareholders of approximately 65.14 million yuan, a decline of 2.74% year-on-year [1] - The company's debt ratio stands at 74.98%, with an investment income of -10.8849 million yuan and financial expenses of 139 million yuan, while the gross profit margin is 6.96% [1]

Group 1 - Zhongwei Company plans to acquire controlling stake in Hangzhou Zhonggui through share issuance, with stock suspension starting December 19, 2025, for up to 10 trading days [1] - Qibin Group's subsidiary plans to establish Shenzhen Qibin New Energy Technology Co., with a registered capital of 600 million yuan to enhance photovoltaic glass supply chain efficiency [2] - Boying Special Welding's HRSG equipment is primarily matched with heavy gas turbines, with a production cycle of about 6 months, responding to increased demand in the U.S. market [3] Group 2 - Hongda Electronics' associate Jiangsu Zhanxin's application for IPO on the ChiNext has been accepted, with Hongda holding 13.79% of shares prior to the offering [5] - Yinxing Energy plans to acquire 50% stake in Tianjing Shenzhou for 20.15275 million yuan, which will enhance its renewable energy capacity [6] - Nandu Power's controlling shareholder has terminated plans for a change in control, leading to stock resumption on December 19, 2025 [7] Group 3 - Xibu Mining's subsidiary has obtained a mining license for iron resources, supporting sustainable development in the iron resource sector [9] - Shandong Expressway plans to provision for a long-term equity investment impairment of approximately 690 million yuan related to Dongxing Securities [10] - Tianfeng Securities has signed a supplementary agreement to extend the term of a 4 billion yuan subordinated debt by one year, with an adjusted interest rate of 4% [11] Group 4 - Shandong Zhanggu has received an administrative regulatory decision from the Shandong Securities Regulatory Commission for various compliance issues [12] - Nanjing Pharmaceutical plans to invest 120 million yuan to establish a medical device investment company, focusing on acquiring a stake in Ningbo Jiangfeng [13] - Hailianxun has received approval from the CSRC for a share swap merger with Hangzhou Steam Turbine, proceeding with related transactions [14] Group 5 - Luyuan Pharmaceutical reports normal operations with no significant changes in the internal and external business environment [15] - Nanhua Futures has set the H-share public offering price at 12 HKD per share, with expected listing on December 22, 2025 [17] - Visionox plans to invest 3.918 billion yuan in the second phase of the Hefei Guoxian AMOLED production line project, increasing its stake to 37.73% [18] Group 6 - Sichuan Road and Bridge has been acquired by Zhong Postal Insurance, reaching a 5% stake [19] - Boshuo Technology's directors plan to reduce their holdings by up to 18,300 shares [20] - O-film's controlling shareholder transferred 67.7048 million shares to settle debts, maintaining control with a 5.78% stake post-transfer [21] Group 7 - Junshi Biosciences' shareholder plans to reduce holdings by up to 2% through block trading [22] - Lihu Co. plans to reduce holdings by up to 2.98% through various trading methods [23] - Ruichen Environmental plans to reduce holdings by up to 3% through trading [25] Group 8 - Zhongfutong received a winning bid notification for a project worth approximately 411 million yuan [29] - Shikong Technology won a 141 million yuan project for smart cultural tourism integration [30] - Ningbo Construction's subsidiary won a 747 million yuan engineering project [31]

（编辑 任世碧） 证券日报网讯 12月18日晚间，鹭燕医药发布公告称，公司股票交易价格连续两个交易日内（2025年12 月17日、2025年12月18日）收盘价格涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核 实，前期披露的信息不存在需要更正、补充之处；近期公司经营情况正常，内外部经营环境未发生重大 变化；公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的未公开重大信 息。 ...

Market Overview - The overall market sentiment is described as ordinary, with the ChiNext index showing a significant decline of 2.17% while the Shanghai Composite Index slightly increased by 0.16% [1] - Various sectors experienced mixed performances, with notable gains in AI healthcare and retail, while sectors like Hainan and lithium batteries faced declines [1] Reward Economy - The concept of "Reward Economy" has gained attention, defined as consumers purchasing non-essential items or experiences to alleviate work and life pressures, reflecting a growing trend among younger consumers [5][6] - The Chinese潮玩 (trendy toy) market is projected to reach a market size of 110.1 billion yuan by 2026, indicating substantial growth potential [6] AI Healthcare - AI healthcare stocks rebounded strongly, with companies like Luyuan Pharmaceutical and Meinian Health achieving consecutive gains, while the sector overall rose by 4.23% [11] - The catalyst for this surge was the recent upgrade of Ant Group's AI health app, "Antifufu," which has over 15 million monthly active users, positioning it as a leading health management AI app in China [11] Lithography Machine Sector - The lithography machine sector saw a strong opening, particularly for stocks like New Kylin, which experienced significant gains, although the sector ultimately closed down by 0.56% [14][15] Fujian Sector - The Fujian sector displayed mixed results, with strong performances from traditional leaders like Luyuan Pharmaceutical and Jiumu Wang, while other stocks faced declines [18] - The overall Fujian sector rose by 1.23%, contrasting with the Hainan sector, which saw a significant drop of 3.37% [18]

Market Overview - A total of 61 stocks hit the daily limit up, while 19 stocks faced limit down, resulting in a sealing rate of 76% [1] - The Shanghai Composite Index rose by 0.16%, while the Shenzhen Component Index and the ChiNext Index fell by 1.29% and 2.17% respectively [1] - The total trading volume in the Shanghai and Shenzhen markets was 1.66 trillion, a decrease of 155.7 billion from the previous trading day [1] Stock Performance - Baida Group achieved a six-day limit up streak, while Shengtong Energy and Pinao recorded five and four consecutive limit ups respectively [1][3] - The number of stocks advancing was nearly 2900, with notable performances in the pharmaceutical, banking, and retail sectors [1] - The commercial aerospace concept saw a resurgence, with stocks like Shunhao and Xibu Materials hitting limit up after previous declines [3][5] Sector Analysis - The pharmaceutical commercial sector experienced significant growth due to increased orders amid a rise in respiratory diseases during the winter season [14][15] - The retail sector, particularly driven by the "reward economy," showed strong performance with stocks like Baida Group and Nanjing Shanglv achieving consecutive limit ups [6][12] - The AI healthcare sector remained active, with Ant Group's AI health app "Antifortune" gaining popularity, leading to limit ups for companies like Meian Health and Huaren Health [7][19] Investment Themes - The commercial aerospace sector is highlighted as a strategic emerging industry, with government support and recent rocket launches boosting investor sentiment [5] - The "reward economy" is emerging as a new consumption model among younger demographics, contributing to the growth of related sectors [6][12] - The IP economy is gaining traction, with government initiatives aimed at promoting new consumption models and financial support for innovative businesses [16] Future Outlook - The market is expected to continue experiencing volatility, with a focus on small-cap stocks and growth sectors as larger stocks face profit-taking [9] - The Shanghai Composite Index is attempting to recover above key moving averages, indicating potential for further upward movement if trading volume increases [9]

每经AI快讯，12月18日，鹭燕医药(002788.SZ)公告称，公司股票交易价格连续两个交易日内收盘价格 涨幅偏离值累计超过20%，属于股票交易异常波动的情况。经核实，公司前期披露的信息不存在需要更 正、补充之处，近期公司经营情况正常，内外部经营环境未发生重大变化，公司、控股股东和实际控制 人不存在关于本公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。股票异常波动期间， 控股股东、实际控制人不存在买卖公司股票的情形。 ...

人民财讯12月18日电，鹭燕医药（002788）12月18日发布股票交易异常波动的公告，近期公司经营情况 正常，内外部经营环境未发生重大变化。公司、控股股东和实际控制人不存在关于本公司的应披露而未 披露的重大事项，或处于筹划阶段的重大事项。股票异常波动期间，控股股东、实际控制人不存在买卖 公司股票的情形。 ...

证券代码：002788 证券简称：鹭燕医药 公告编号：2025-029 关于公司股票交易异常波动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 一、股票交易异常波动的情况 鹭燕医药股份有限公司（以下简称"公司"）股票交易价格连续两个交易日内（2025 年 12 月 17 日、2025 年 12 月 18 日）收盘价格涨幅偏离值累计超过 20%，根据深圳证券交易所 的有关规定，属于股票交易异常波动的情况。 二、公司关注并核实相关情况 针对公司股票交易异常波动情况，根据相关规定的要求，公司对有关事项进行了核查， 现就相关情况说明如下： 1、前期披露的信息不存在需要更正、补充之处； 2、近期公司经营情况正常，内外部经营环境未发生重大变化； 3、公司未发现近期公共传媒报道了可能或已经对本公司股票交易价格产生较大影响的 未公开重大信息； 鹭燕医药股份有限公司 5、股票异常波动期间，控股股东、实际控制人不存在买卖公司股票的情形。 三、不存在应披露而未披露信息的说明 本公司董事会确认，本公司目前没有任何根据《深圳证券交易所股票上市规则》等有关 规定应予以披露而未披露 ...